Monday, July 20, 2026

Intelligence · Clinical pipeline

Neurology & CNS · Approved programs

Neurology & CNS programs at Approved programs — ClinicalTrials.gov pipeline intelligence.

Programs 10

Quick answer

Neurology & CNS Approved programs programs: NovaPharmaNews indexes 10 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Pipeline programs

  1. Aripiprazole

    Otsuka Beijing Research Institute

    Schizophrenia

    approved small molecule completed

    3 trials
  2. Clozapine

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial
  3. Iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Schizophrenia

    approved small molecule active

    5 trials
  4. Minocycline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial
  5. PERSERIS

    Indivior Pty Ltd

    Schizophrenia

    approved small molecule completed

    1 trial
  6. Paliperidone ER

    Hospital Authority, Hong Kong

    Schizophrenia

    approved small molecule completed

    1 trial
  7. Ramelteon

    Takeda

    Schizophrenia

    approved small molecule completed

    1 trial
  8. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    approved small molecule active

    3 trials
  9. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    2 trials
  10. Vortioxetine

    Takeda

    Schizophrenia

    approved small molecule active

    1 trial

Frequently asked questions

How many neurology & cns Approved programs programs exist?

10 programs match both the therapeutic area and stage filters in our published index.